| [1] Fearnhead H O, Rodriguez J, Govek E E, et al. Oncogene-dependent apoptosis is mediated by caspase-9. Proc Natl Acad Sci USA, 1998, 95(23):13664-13669.
[2] Hanahan D, Weinberg R A. Hallmarks of cancer:the next generation. Cell, 2011, 144(5):646-674.
[3] Singh P K, Tiwari A K, Rajmani R S, et al. Apoptin as a potential viral gene oncotherapeutic agent. Appl Biochem Biotechnol, 2015, 176(1):196-212.
[4] Saxena S, Kumar R, Singh P, et al. Prokaryotic expression of chicken infectious anemia apoptin protein and characterization of its polyclonal antibodies. Indian J Exp Biol, 2012, 50(5):325-331.
[5] Maddika S, Booy E P, Johar D, et al. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J Cell Sci, 2005, 118(pt19):4485-4493.
[6] Kuusisto H V, Wagstaff K M, Alvisi G, et al. The C-terminus of apoptin represents a unique tumor cell-enhanced nuclear targeting module. Int J Cancer, 2008, 123(12):2965-2969.
[7] Lin B, Kolluri S K, Lin F, et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell, 2004, 116(4):527-540.
[8] Poon I K, Oro C, Dias M M, et al. Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res, 2005, 65(16):7059-7064.
[9] Rollano Peñaloza O M, Lewandowska M, Stetefeld J, et al. Apoptins:selective anticancer agents. Trends Mol Med, 2014, 20(9):519-528.
[10] 张艳玲, 徐 霞, 江露含, 等. 凋亡素原核表达载体构建及活性测定. 中国组织工程研究, 2015, 19(18):2928-2932. Zhang Y L, Xu X, Jiang L H, et al. Construction of a prokaryotic expression vector for apoptin and activity determination. Chinese Journal of Tissue Engineering Research, 2015, 19(18):2928-2932.
[11] 许鑫, 仲雨微, 李其久, 等. TAT-Apoptin 蛋白制备及其诱导BGC-823细胞的凋亡作用. 南开大学学报(自然科学版), 2015, 48(5):33-37. Xu X, Zhong Y W, Li Q J, et al. TAT-Apoptin protein preparation and induction of apoptosis of BGC-823 cell. Acta Scientiarum Naturalium Universitatis Nankaiensis, 2015, 48(5):33-37.
[12] Xie Q M, Ji J, Du L Q, et a. Preparation and immune activity analysis of H5N1 subtype avian influenza virus recombinant protein-based vaccine. Poult Sci, 2009, 88(8):1608-1615.
[13] Jin J L, Gong J, Yin T J, et al. PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo. Eur J Pharmacol, 2011, 654(1):17-25.
[14] Pennant W A, An S, Gwak S J, et al. Local non-viral gene delivery of apoptin delays the onset of paresis in an experimental model of intramedullary spinal cord tumor. Spinal Cord, 2014, 52(1):3-8.
[15] Yuan L, Zhao H, Zhang L, et al. The efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma. Tumour Biol, 2013, 34(5):3027-3034.
[16] Ma J L, Han S X, Zhao J, et al. Systemic delivery of lentivirus-mediated secretable TAT-apoptin eradicates hepatocellular carcinoma xenografts in nude mice. Int J Oncol, 2012, 41(3):1013-1020.
[17] Wu Y, Zhang X, Wang X, et al. Apoptin enhances the oncolytic properties of Newcastle disease virus. Intervirology, 2012, 55(4):276-286.
[18] Sun J, Yan Y, Wang X T, et al. PTD4-apoptin protein therapy inhibits tumor growth in vivo. Int J Cancer, 2009, 124(1):2973-2981.
[19] 郭争荣, 彭焕彦, 亢继文,等. 细胞穿透肽:一种新型非病毒载体. 中国生物工程杂志, 2016, 36(6):100-106. Guo Z R, Peng H Y, Kang J W, et al. Cell penetrating peptides:research progress of a novel non-viral vectors. China Biotechnology, 2016, 36(6):100-106.
[20] 刘雪梅, 崔剑, 侯伟健, 等. TAT-Apoptin融合蛋白分泌表达载体的构建及其活性检测. 中国医科大学学报, 2013, 42(1):45-48. Liu X M, Cui J, Hou W J, et al. Construction of prokaryotic secretory expression vector of TAT-apoptin and expression in E. coli. Journal of China Medical University, 2013, 42(1):45-48. |
